AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10991842 — intervention group
Group type: EXPERIMENTAL
Intervention: saquinavir-SGC (1,200 to 1,800 mg) plus ritonavir (100 to 200 mg)
Number of subjects: 44
Study 10991842 — intervention group
Group type: COMPARATOR
Intervention: saquinavir-SGC (1,200 mg) three times daily
Number of subjects: 44
Study 8969617 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0
Study 8969617 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D treatment
Number of subjects: 0
Study 8969617 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise interventions
Number of subjects: 0
Study 8969617 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy and bisphosphonates
Number of subjects: 0
Study 1311663 — intervention group
Group type: EXPERIMENTAL
Intervention: 111In‐labelled granulocytes
Number of subjects: 8
Study 3993612 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient-rich dietary supplement (group A)
Number of subjects: 225
Study 3993612 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 225
Study 31575824 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot-toe orthosis and laboratory-issued shoe group
Number of subjects: 64
Study 31575824 — intervention group
Group type: COMPARATOR
Intervention: Laboratory-issued shoe only (SO) group
Number of subjects: 64
Study 31575824 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study 28771018 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
Number of subjects: 46
Study 28771018 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 46
Study 27973414 — intervention group
Group type: EXPERIMENTAL
Intervention: Height-adjustable desks with pedagogical strategies to reduce/break-up sitting
Number of subjects: 48
Study 27973414 — intervention group
Group type: COMPARATOR
Intervention: Traditional furniture (control)
Number of subjects: 48
Study 23908187 — intervention group
Group type: EXPERIMENTAL
Intervention: FIN-RACo+INFL (infliximab 3 mg/kg)
Number of subjects: 99
Study 23908187 — intervention group
Group type: COMPARATOR
Intervention: FIN-RACo+PLA (placebo)
Number of subjects: 99
Study 22749176 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamon extract (low-dose at 120 mg/d)
Number of subjects: 66
Study 22749176 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamon extract (high-dose at 360 mg/d)
Number of subjects: 66
Study 22749176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 20414661 — intervention group
Group type: EXPERIMENTAL
Intervention: Disimpaction for the first week and daily laxative (Group A1)
Number of subjects: 270
Study 20414661 — intervention group
Group type: COMPARATOR
Intervention: Only daily laxative (Group A2)
Number of subjects: 270
Study 20414661 — intervention group
Group type: EXPERIMENTAL
Intervention: Disimpaction for the first week and daily laxative (Group B1)
Number of subjects: 270
Study 20414661 — intervention group
Group type: COMPARATOR
Intervention: Only daily laxative (Group B2)
Number of subjects: 270
Study 18689552 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil (6 g of ALA)
Number of subjects: 0
Study 18689552 — intervention group
Group type: EXPERIMENTAL
Intervention: Milled flaxseed (30 g)
Number of subjects: 0
Study 18689552 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole flaxseed (30 g)
Number of subjects: 0
Study 18689552 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 0
Study 16422825 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg on-demand treatment
Number of subjects: 4262
Study 16422825 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 3 times/week treatment
Number of subjects: 4262
Study 16422825 — intervention group
Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 4262
Study 15540759 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin 8 mg with Tadalafil 20 mg
Number of subjects: 36
Study 15540759 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg with Tadalafil 10 mg
Number of subjects: 36
Study 15540759 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg with Tadalafil 20 mg
Number of subjects: 36
Study 11375359 — intervention group
Group type: EXPERIMENTAL
Intervention: Group consultations every 3 months
Number of subjects: 112
Study 11375359 — intervention group
Group type: COMPARATOR
Intervention: Individual visits plus support education every 3 months
Number of subjects: 112
Study 9245040 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 30
Study 9245040 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 30
Study 9245040 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 30
Study 8488476 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 12
Study 8488476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3553274 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential fatty acid (EFA) supplementation (evening primrose oil; Efamol)
Number of subjects: 31
Study 3553274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 30426183 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 0
Study 30426183 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 0
Study 30426183 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG spectra
Number of subjects: 0
Study 26859644 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stockings (24 or 30 mmHg ankle pressure)
Number of subjects: 9
Study 26859644 — intervention group
Group type: COMPARATOR
Intervention: Regular stockings (no compression)
Number of subjects: 9
Study 24935082 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication management plus CBT
Number of subjects: 144
Study 24935082 — intervention group
Group type: COMPARATOR
Intervention: Medication management only
Number of subjects: 144
Study 22874692 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular diclofenac 75 mg
Number of subjects: 60
Study 22874692 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal diclofenac
Number of subjects: 60
Study 21029642 — intervention group
Group type: EXPERIMENTAL
Intervention: Supreme LMA (S)
Number of subjects: 125
Study 21029642 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube (T)
Number of subjects: 125
Study 19128643 — intervention group
Group type: EXPERIMENTAL
Intervention: DizzyFix device
Number of subjects: 50
Study 19128643 — intervention group
Group type: COMPARATOR
Intervention: Non-device users (control)
Number of subjects: 50
Study 16400464 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet (D)
Number of subjects: 53
Study 16400464 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus exercise training (D + ET)
Number of subjects: 53
Study 16400464 — intervention group
Group type: COMPARATOR
Intervention: Nonadherent (NA)
Number of subjects: 53
Study 15643758 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing stick (miswak)
Number of subjects: 15
Study 15643758 — intervention group
Group type: COMPARATOR
Intervention: Toothbrushing
Number of subjects: 15
Study 11341172 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of anti-insulin antibodies (AB1)
Number of subjects: 0
Study 11341172 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated levels of antiidiotypic antibodies (AIAb2)
Number of subjects: 0
Study 11341172 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of anti-insulin/NGF Ab1
Number of subjects: 0
Study 11341172 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with elevated levels of Ab1 at age 1-3 years
Number of subjects: 0
Study 8780345 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean mass
Number of subjects: 1600
Study 8780345 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat mass
Number of subjects: 1600
Study 8780345 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight
Number of subjects: 1600
Study 1384299 — intervention group
Group type: EXPERIMENTAL
Intervention: cetirizine 10 mg
Number of subjects: 6
Study 1384299 — intervention group
Group type: COMPARATOR
Intervention: terfenadine 60 mg
Number of subjects: 6
Study 2999514 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone aftercare contacts every 2 weeks for 1 year
Number of subjects: 0
Study 2999514 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment (control group)
Number of subjects: 0
Study 2999514 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone aftercare contacts
Number of subjects: 0
Study 30440913 — intervention group
Group type: EXPERIMENTAL
Intervention: 1Hz rTMS treatment 4 days/week for 3 weeks followed by 30min occupational therapy (OT)
Number of subjects: 4
Study 30440913 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS for 3 weeks followed by sham rTMS combined with OT for 3 weeks
Number of subjects: 4
Study 26784537 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT) for aggression, 12 sessions
Number of subjects: 80
Study 26784537 — intervention group
Group type: COMPARATOR
Intervention: Supportive psychotherapy, 12 sessions
Number of subjects: 80
Study 25180279 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 0
Study 25180279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22494016 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular (BIV) pacing
Number of subjects: 11
Study 22494016 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular (RV) pacing
Number of subjects: 11
Study 19900348 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted strategy training for executive dysfunction
Number of subjects: 75
Study 19900348 — intervention group
Group type: COMPARATOR
Intervention: Computerized cognitive function training
Number of subjects: 75
Study 19093057 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 31
Study 19093057 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole plus amoxicillin
Number of subjects: 31
Study 16280177 — intervention group
Group type: EXPERIMENTAL
Intervention: Foscarnet (1 g/day for 4 weeks)
Number of subjects: 65
Study 16280177 — intervention group
Group type: EXPERIMENTAL
Intervention: Foscarnet (in vitro and in vivo)
Number of subjects: 65
Study 16280177 — intervention group
Group type: EXPERIMENTAL
Intervention: Foscarnet (in vivo)
Number of subjects: 65
Study 12438980 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with flatback deformity
Number of subjects: 21
Study 12438980 — intervention group
Group type: COMPARATOR
Intervention: Normal healthy individuals
Number of subjects: 21
Study 10048641 — intervention group
Group type: EXPERIMENTAL
Intervention: Philips HP 735 powered toothbrush
Number of subjects: 75
Study 10048641 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun/Oral B D7 powered toothbrush
Number of subjects: 75
Study 10048641 — intervention group
Group type: COMPARATOR
Intervention: Oral B Advantage B35 manual toothbrush
Number of subjects: 75
Study 7560663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (10 mg)
Number of subjects: 13
Study 7560663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg)
Number of subjects: 13
Study 7560663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 2134003 — intervention group
Group type: EXPERIMENTAL
Intervention: Beveled preparations
Number of subjects: 43
Study 2134003 — intervention group
Group type: COMPARATOR
Intervention: Non-beveled preparations
Number of subjects: 43
Study 7002477 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide and oxprenolol
Number of subjects: 20
Study 7002477 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide alone
Number of subjects: 20
Study 7002477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30557080 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous steroid injection after percutaneous A1 pulley release
Number of subjects: 112
Study 30557080 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous A1 pulley release alone
Number of subjects: 112
Study 28495619 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin DPI 32.5mg twice daily
Number of subjects: 0
Study 28495619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26368396 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (OT)
Number of subjects: 156
Study 26368396 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo or no treatment)
Number of subjects: 156
Study 23373793 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + aPDT
Number of subjects: 15
Study 23373793 — intervention group
Group type: COMPARATOR
Intervention: SRP
Number of subjects: 15
Study 21311753 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory content with categorical similarity (digits)
Number of subjects: 0
Study 21311753 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory content
Number of subjects: 0
Study 21311753 — intervention group
Group type: COMPARATOR
Intervention: Control condition (colors and digits)
Number of subjects: 0
Study 19586135 — intervention group
Group type: COMPARATOR
Intervention: Standard care plus assessment (SC)
Number of subjects: 0
Study 19586135 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus brief motivational intervention (BI)
Number of subjects: 0
Study 19586135 — intervention group
Group type: EXPERIMENTAL
Intervention: BI plus a booster session (BIB)
Number of subjects: 0
Study 19586135 — intervention group
Group type: EXPERIMENTAL
Intervention: BI and BIB
Number of subjects: 0
Study 19586135 — intervention group
Group type: COMPARATOR
Intervention: SC
Number of subjects: 0
Study 17762374 — intervention group
Group type: COMPARATOR
Intervention: EHIGH
Number of subjects: 62
Study 17762374 — intervention group
Group type: COMPARATOR
Intervention: EMODERATE
Number of subjects: 62
Study 15126813 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical diagnostic algorithm for stress urinary incontinence (SUI) based on symptoms and signs
Number of subjects: 1455
Study 11403530 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 0
Study 11403530 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphetamine
Number of subjects: 0
Study 11403530 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine
Number of subjects: 0
Study 11403530 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 0
Study 11403530 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0
Study 11403530 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 0
Study 11403530 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemoline
Number of subjects: 0
Study 11403530 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants
Number of subjects: 0
Study 11403530 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study 11403530 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled naps
Number of subjects: 0
Study 10894290 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Method (SM) counseling (male or female condoms only)
Number of subjects: 1591
Study 10894290 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchical Message (HP) counseling (male condoms, female condoms, diaphragms, cervical caps, and spermicides)
Number of subjects: 1591
Study 8895711 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine 100 mg IM intraoperative preprocedure
Number of subjects: 125
Study 8895711 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine 100 mg IM intraoperative postprocedure
Number of subjects: 125
Study 8895711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 60 mg IM intraoperative preprocedure
Number of subjects: 125
Study 8895711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 60 mg IM postprocedure
Number of subjects: 125
Study 8895711 — intervention group
Group type: COMPARATOR
Intervention: Control placebo
Number of subjects: 125
Study 1364801 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined roentgenoradionuclide investigation of the lungs
Number of subjects: 45
Study 6343155 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 300 mg/day
Number of subjects: 118
Study 6343155 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 750 mg/day
Number of subjects: 118
Study 30611135 — intervention group
Group type: EXPERIMENTAL
Intervention: Strokectomy after decompressive craniectomy
Number of subjects: 198
Study 30611135 — intervention group
Group type: EXPERIMENTAL
Intervention: Strokectomy in patients with infarctions in more than one vascular territory
Number of subjects: 198
Study 30611135 — intervention group
Group type: COMPARATOR
Intervention: Strokectomy group vs. matched control group
Number of subjects: 198
Study 30611135 — intervention group
Group type: EXPERIMENTAL
Intervention: Strokectomy group
Number of subjects: 198
Study 30611135 — intervention group
Group type: EXPERIMENTAL
Intervention: Münster Stroke Score ≥ 3
Number of subjects: 198
Study 29394211 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 700
Study 29394211 — intervention group
Group type: EXPERIMENTAL
Intervention: Other Nerve Stimulation Therapies (NSTs)
Number of subjects: 700
Study 29394211 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (sham, placebo, or medication only)
Number of subjects: 700
Study 27129840 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based yoga
Number of subjects: 34
Study 27129840 — intervention group
Group type: COMPARATOR
Intervention: Strengthening exercises
Number of subjects: 34
Study 25345982 — intervention group
Group type: EXPERIMENTAL
Intervention: RIF‐MMX (2×200 mg twice daily for 3 days)
Number of subjects: 264
Study 25345982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study 25345982 — intervention group
Group type: EXPERIMENTAL
Intervention: RIF‐MMX
Number of subjects: 264
Study 22772089 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional communication intervention involving a trained communication facilitator (nurse or social worker)
Number of subjects: 0
Study 20397782 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazard perception training package
Number of subjects: 20
Study 20397782 — intervention group
Group type: COMPARATOR
Intervention: Control intervention video
Number of subjects: 20
Study 18628111 — intervention group
Group type: EXPERIMENTAL
Intervention: Hitting a ball dropped from a ramp from 5 heights (1.5, 2.0, 2.5, 3.0, and 3.5 m)
Number of subjects: 9
Study 18628111 — intervention group
Group type: EXPERIMENTAL
Intervention: Hitting a moving ball while stepping
Number of subjects: 9
Study 15901742 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone cream 40 mg twice daily for 12 days
Number of subjects: 12
Study 15901742 — intervention group
Group type: COMPARATOR
Intervention: Oral progesterone capsules 200 mg once daily for 12 days
Number of subjects: 12
Study 12556074 — intervention group
Group type: EXPERIMENTAL
Intervention: Low calcium dialysate (1.25 mmol/L calcium)
Number of subjects: 28
Study 12556074 — intervention group
Group type: COMPARATOR
Intervention: Standard dialysate (1.75 mmol/L calcium)
Number of subjects: 28
Study 12556074 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 28
Study 10047632 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF)
Number of subjects: 3465
Study 10047632 — intervention group
Group type: COMPARATOR
Intervention: Sinus rhythm
Number of subjects: 3465
Study 10047632 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and body weight
Number of subjects: 3465
Study 10047632 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged duration of AF, left ventricular dilatation, increased muscle mass, mitral regurgitation, annular calcification, and hypertension
Number of subjects: 3465
Study 7726669 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental enteral feeding (arginine + omega-3 fatty acids)
Number of subjects: 60
Study 7726669 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral feeding
Number of subjects: 60
Study 7726669 — intervention group
Group type: EXPERIMENTAL
Intervention: Tube feeding
Number of subjects: 60
Study 7726669 — intervention group
Group type: COMPARATOR
Intervention: No tube feeding
Number of subjects: 60
Study 2291881 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml of 0.25% bupivacaine plain
Number of subjects: 55
Study 2291881 — intervention group
Group type: COMPARATOR
Intervention: 10 ml of 0.25% bupivacaine with epinephrine 1:200,000
Number of subjects: 55
Study 31714636 — intervention group
Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitors
Number of subjects: 81403
Study 31714636 — intervention group
Group type: COMPARATOR
Intervention: HMGCR, APOB, NPC1L1 (statins, ezetimibe, mipomersen)
Number of subjects: 81403
Study 30106523 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health promotion program in primary schools
Number of subjects: 740
Study 30106523 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 740
Study 30106523 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health promotion program in primary schools (for high socio-economic status)
Number of subjects: 740
Study 30106523 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health promotion program in primary schools (for low socio-economic status)
Number of subjects: 740
Study 26872721 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicory inulin (10g daily for 2 months)
Number of subjects: 46
Study 26872721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 24063291 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-session group-based intervention
Number of subjects: 92
Study 24063291 — intervention group
Group type: COMPARATOR
Intervention: No-intervention, assessment-only control condition
Number of subjects: 92
Study 22180317 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL) treatment with a spectral range of 500-670 and 870-1,200 nm, fluence range of 34-70 J/cm(2), 10 mm × 15 mm spot, pulse width of 10 or 100 mseconds, and 5°C contact cooling.
Number of subjects: 16